Table 2

Univariate and multivariate analysis of factors influencing absolute sjTREC (number per mm3 of blood) reconstitution after HSCT

FactornP
Univariate analysis by time point, mo
Multivariate analysis by time point, mo*
Before3612Before3612
aGVHD (0/I-IV) 25/68   .019 .009   .049 .288 
cGVHD (no/yes) 46/40  .036  .001  .194  .064 
Age (< 25 y/ ≥ 25 y) 31/62 .015 .048 .036 < .001 .800 .278 .006 .022 
Stem cell source (BM/PB) 56/37 .004   .044 .174   .687 
TBI (yes/no) 45/48         
Myeloablative conditioning (yes/no) 79/14         
Underlying disease (malignant/not malignant) 81/12 < .001    .040    
FactornP
Univariate analysis by time point, mo
Multivariate analysis by time point, mo*
Before3612Before3612
aGVHD (0/I-IV) 25/68   .019 .009   .049 .288 
cGVHD (no/yes) 46/40  .036  .001  .194  .064 
Age (< 25 y/ ≥ 25 y) 31/62 .015 .048 .036 < .001 .800 .278 .006 .022 
Stem cell source (BM/PB) 56/37 .004   .044 .174   .687 
TBI (yes/no) 45/48         
Myeloablative conditioning (yes/no) 79/14         
Underlying disease (malignant/not malignant) 81/12 < .001    .040    

aGvHD indicates acute GvHD; and cGvHD, chronic GvHD. All other abbreviations are as in Table 1.

*

For each time point, only factors found to be significant in univariate analyses were included in the multivariate analyses.

P > .05 (not significant).

or Create an Account

Close Modal
Close Modal